Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
7.84
+0.04 (0.51%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cogent Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 97.05 | 53.23 | 139.89 | 219.68 | 242.19 | 37.42 | Upgrade
|
Short-Term Investments | 238.47 | 212.48 | 119.39 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 335.52 | 265.71 | 259.28 | 219.68 | 242.19 | 37.42 | Upgrade
|
Cash Growth | 20.24% | 2.48% | 18.02% | -9.29% | 547.15% | 32.38% | Upgrade
|
Receivables | - | - | - | - | - | 2 | Upgrade
|
Prepaid Expenses | 6.01 | 5.06 | 4.44 | 2.95 | 2.72 | 1.17 | Upgrade
|
Restricted Cash | - | - | 1.26 | - | - | - | Upgrade
|
Total Current Assets | 341.53 | 270.77 | 264.97 | 222.63 | 244.91 | 40.59 | Upgrade
|
Property, Plant & Equipment | 27.6 | 30.34 | 31.1 | 4.48 | 4.75 | 7.15 | Upgrade
|
Long-Term Investments | 10.03 | 7.46 | - | - | - | - | Upgrade
|
Other Long-Term Assets | 4.86 | 4.86 | 4.75 | 4.98 | 1.26 | 1.68 | Upgrade
|
Total Assets | 384.02 | 313.44 | 300.81 | 232.09 | 250.92 | 49.42 | Upgrade
|
Accounts Payable | 15.06 | 10.66 | 5.84 | 3.48 | 0.73 | 3.18 | Upgrade
|
Accrued Expenses | 36.16 | 25.69 | 17.48 | 7.98 | 4.47 | 6.24 | Upgrade
|
Current Portion of Leases | 1.52 | 1.39 | 1.42 | 2.32 | 2.05 | 1.62 | Upgrade
|
Current Unearned Revenue | - | - | - | - | - | 1.32 | Upgrade
|
Other Current Liabilities | 0.31 | 0.44 | 2.1 | 3.3 | 5.84 | 0.89 | Upgrade
|
Total Current Liabilities | 53.05 | 38.17 | 26.85 | 17.08 | 13.09 | 13.25 | Upgrade
|
Long-Term Leases | 16.31 | 17.47 | 18.23 | 0.83 | 3.16 | 4.41 | Upgrade
|
Total Liabilities | 69.36 | 55.64 | 45.08 | 17.91 | 16.25 | 17.66 | Upgrade
|
Common Stock | 0.11 | 0.09 | 0.07 | 0.04 | 0.03 | 0.01 | Upgrade
|
Additional Paid-In Capital | 994.61 | 801.06 | 601.15 | 399.71 | 322.45 | 155.65 | Upgrade
|
Retained Earnings | -791.56 | -603.62 | -411.21 | -270.97 | -198.7 | -123.89 | Upgrade
|
Comprehensive Income & Other | 0.9 | 0.25 | -0.1 | - | - | - | Upgrade
|
Total Common Equity | 204.06 | 197.77 | 189.91 | 128.78 | 123.79 | 31.76 | Upgrade
|
Shareholders' Equity | 314.66 | 257.8 | 255.74 | 214.18 | 234.67 | 31.76 | Upgrade
|
Total Liabilities & Equity | 384.02 | 313.44 | 300.81 | 232.09 | 250.92 | 49.42 | Upgrade
|
Total Debt | 17.83 | 18.85 | 19.65 | 3.16 | 5.21 | 6.03 | Upgrade
|
Net Cash (Debt) | 327.72 | 254.32 | 239.63 | 216.53 | 236.98 | 31.39 | Upgrade
|
Net Cash Growth | 11.60% | 6.13% | 10.67% | -8.63% | 654.92% | - | Upgrade
|
Net Cash Per Share | 3.35 | 3.19 | 4.08 | 5.59 | 21.39 | 4.12 | Upgrade
|
Filing Date Shares Outstanding | 110.46 | 103.91 | 69.95 | 45.81 | 37.19 | 7.67 | Upgrade
|
Total Common Shares Outstanding | 110.46 | 86.12 | 69.89 | 43.81 | 32.35 | 7.67 | Upgrade
|
Working Capital | 288.48 | 232.6 | 238.12 | 205.56 | 231.82 | 27.34 | Upgrade
|
Book Value Per Share | 1.85 | 2.30 | 2.72 | 2.94 | 3.83 | 4.14 | Upgrade
|
Tangible Book Value | 204.06 | 197.77 | 189.91 | 128.78 | 123.79 | 31.76 | Upgrade
|
Tangible Book Value Per Share | 1.85 | 2.30 | 2.72 | 2.94 | 3.83 | 4.14 | Upgrade
|
Machinery | - | 9.54 | 6.93 | 1.21 | 0.14 | 6.07 | Upgrade
|
Construction In Progress | - | 0.03 | 0.48 | 0.65 | - | - | Upgrade
|
Leasehold Improvements | - | 2.44 | 1.78 | 0.41 | 0.41 | 0.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.